Efficacy and Safety of Valsartan and Amlodipine (± HCTZ) in Adults With Moderate, Inadequately Controlled Hypertension

NCT00523744 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

257

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: Amlodipine
DRUG: Olmesartan medoxomil
DRUG: Amlodipine+valsartan
DRUG: Hydrochlorothiazide

Sponsor

Novartis